215 related articles for article (PubMed ID: 6400038)
21. A rapid and efficient in vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of cancer.
Staquet K; Giles-Komar J
Hybridoma (Larchmt); 2006 Apr; 25(2):68-74. PubMed ID: 16704306
[TBL] [Abstract][Full Text] [Related]
22. An extreme strategy for the production of hybridoma.
Golestani R; Pourfathollah AA; Moazzeni SM
Hybridoma (Larchmt); 2009 Apr; 28(2):139-44. PubMed ID: 19249989
[TBL] [Abstract][Full Text] [Related]
23. Use of a murine T-cell hybridoma expressing human T-cell receptor alpha- and beta-gene products as a tool for the production of human T-cell receptor-specific monoclonal antibodies.
Zumla A; McCormack A; George A; Batchelor R; Lechler R
Hum Immunol; 1992 Nov; 35(3):141-8. PubMed ID: 1293080
[TBL] [Abstract][Full Text] [Related]
24. Efficient preparation of human monoclonal antibody-secreting heterohybridomas using peripheral B lymphocytes cultured in the CD40 system.
Darveau A; Chevrier MC; Néron S; Delage R; Lemieux R
J Immunol Methods; 1993 Feb; 159(1-2):139-43. PubMed ID: 7680365
[TBL] [Abstract][Full Text] [Related]
25. A human monoclonal antibody to cytomegalovirus (CMV).
Emanuel D; Gold J; Colacino J; Lopez C; Hammerling U
J Immunol; 1984 Oct; 133(4):2202-5. PubMed ID: 6088634
[TBL] [Abstract][Full Text] [Related]
26. Preparation of human-mouse heterohybridomas against an immunising antigen.
Jessup CF; Baxendale H; Goldblatt D; Zola H
J Immunol Methods; 2000 Dec; 246(1-2):187-202. PubMed ID: 11121559
[TBL] [Abstract][Full Text] [Related]
27. High-resolution analysis of the B cell repertoire before and after polyethylene glycol fusion reveals preferential fusion of rare antigen-specific B cells.
Dubois AR; Buerckert JP; Sinner R; Faison WJ; Molitor AM; Muller CP
Hum Antibodies; 2016 Jun; 24(1-2):1-15. PubMed ID: 27472868
[TBL] [Abstract][Full Text] [Related]
28. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
Posner MR; Elboim H; Santos D
Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
[TBL] [Abstract][Full Text] [Related]
29. Generation of human monoclonal antibodies to cancer-associated antigens using limited numbers of patient lymphocytes.
Smith LH; Yin A; Bieber M; Teng NN
J Immunol Methods; 1987 Dec; 105(2):263-73. PubMed ID: 2826600
[TBL] [Abstract][Full Text] [Related]
30. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
[TBL] [Abstract][Full Text] [Related]
31. Generation of a human hybridoma producing a pure anti-HLA-A2 monoclonal antibody.
Wallace EF; Foung SK; Bradbury K; Pask SL; Grumet FC
Hum Immunol; 1990 May; 28(1):65-9. PubMed ID: 2160447
[TBL] [Abstract][Full Text] [Related]
32. Hybridoma technologies for antibody production.
Tomita M; Tsumoto K
Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
[TBL] [Abstract][Full Text] [Related]
33. High throughput monoclonal antibody generation by immunizing multiple antigens.
Liu Y; Wang Y; Liu J; Zuo W; Hao L; Zhang L; Zhen B
Sci China Life Sci; 2014 Jul; 57(7):710-7. PubMed ID: 24950620
[TBL] [Abstract][Full Text] [Related]
34. Production of human monoclonal antibodies to B lymphocyte cell surface antigens by in vitro immunization and human-human hybridoma technology.
Power DA; Gerkis V; d'Apice AJ
Hum Antibodies Hybridomas; 1990; 1(1):34-41. PubMed ID: 2103351
[TBL] [Abstract][Full Text] [Related]
35. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
[TBL] [Abstract][Full Text] [Related]
36. The use of an anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation.
Rycyzyn MA; Staquet K; Fisher J; Bannish G; Bassiri A; Duchala C; Giles-Komar J
Hybridoma (Larchmt); 2008 Feb; 27(1):25-30. PubMed ID: 18294073
[TBL] [Abstract][Full Text] [Related]
37. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor.
Zhang YP; Tzartos SJ; Wekerle H
Eur J Immunol; 1988 Feb; 18(2):211-8. PubMed ID: 2450756
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies.
Ackermann R
Hum Cell; 1988 Mar; 1(1):46-53. PubMed ID: 3154013
[TBL] [Abstract][Full Text] [Related]
39. High efficiency creation of human monoclonal antibody-producing hybridomas.
Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
[TBL] [Abstract][Full Text] [Related]
40. A human hybrid hybridoma.
Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
